INGHAM HEALTHCARE LIMITED

Company Registration Number:
05267582 (England and Wales)

Unaudited abridged accounts for the year ended 31 October 2025

Period of accounts

Start date: 01 November 2024

End date: 31 October 2025

INGHAM HEALTHCARE LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2025

Balance sheet
Notes

INGHAM HEALTHCARE LIMITED

Balance sheet

As at 31 October 2025


Notes
2025
2024


£
£
Fixed assets
Intangible assets: 3 203,300 203,300
Tangible assets: 4 1,302,687 1,303,573
Total fixed assets: 1,505,987 1,506,873
Current assets
Stocks: 500 500
Cash at bank and in hand: 16,360 22,114
Total current assets: 16,860 22,614
Creditors: amounts falling due within one year: 5 (298,375) (294,618)
Net current assets (liabilities): (281,515) (272,004)
Total assets less current liabilities: 1,224,472 1,234,869
Creditors: amounts falling due after more than one year: 6 (328,008) (391,654)
Total net assets (liabilities): 896,464 843,215
Capital and reserves
Called up share capital: 1 1
Revaluation reserve:7555,000555,000
Profit and loss account: 341,463 288,214
Shareholders funds: 896,464 843,215

The notes form part of these financial statements

INGHAM HEALTHCARE LIMITED

Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 16 July 2026
and signed on behalf of the board by:

Name: Mr Anver Patel
Status: Director

The notes form part of these financial statements

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Tangible fixed assets and depreciation policy

25% reducing balance

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

2. Employees

2025 2024
Average number of employees during the period 26 26

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

3. Intangible Assets

Total
Cost £
At 01 November 2024 203,300
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 October 2025 203,300
Net book value
At 31 October 2025 203,300
At 31 October 2024 203,300

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

4. Tangible Assets

Total
Cost £
At 01 November 2024 1,549,448
At 31 October 2025 1,549,448
Depreciation
At 01 November 2024 245,875
Charge for year 886
At 31 October 2025 246,761
Net book value
At 31 October 2025 1,302,687
At 31 October 2024 1,303,573

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

5. Creditors: amounts falling due within one year note

Year 2025 2024 Trade Creditors 500 4955 Bank loans & Overdrafts 75805 31493 Other creditors 180336 195336 Taxation & Social Security 41734 62834 Totals 298375 294618

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

6. Creditors: amounts falling due after more than one year note

Year 2005 2004 Other creditors 328008 391654

INGHAM HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

7. Revaluation reserve

2025
£
Balance at 01 November 2024 555,000
Surplus or deficit after revaluation 0
Balance at 31 October 2025 555,000